Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
34.62
+1.37 (4.12%)
May 20, 2026, 4:00 PM EDT - Market closed
Vera Therapeutics Employees
Vera Therapeutics had 249 employees as of December 31, 2025. The number of employees increased by 137 or 122.32% compared to the previous year.
Employees
249
Change
137
Growth
122.32%
Revenue / Employee
n/a
Profits / Employee
-$1,481,739
Market Cap
2.49B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 249 | 137 | 122.32% |
| Sep 30, 2025 | 224 | 142 | 173.17% |
| Jun 30, 2025 | 192 | 120 | 166.67% |
| Mar 31, 2025 | 152 | 97 | 176.36% |
| Dec 31, 2024 | 112 | 61 | 119.61% |
| Sep 30, 2024 | 82 | 33 | 67.35% |
| Jun 30, 2024 | 72 | 23 | 46.94% |
| Mar 31, 2024 | 55 | 9 | 19.57% |
| Dec 31, 2023 | 51 | 5 | 10.87% |
| Sep 30, 2023 | 49 | 8 | 19.51% |
| Jun 30, 2023 | 49 | 20 | 68.97% |
| Mar 31, 2023 | 46 | 28 | 155.56% |
| Dec 31, 2022 | 46 | 29 | 170.59% |
| Sep 30, 2022 | 41 | 26 | 173.33% |
| Jun 30, 2022 | 29 | 16 | 123.08% |
| Mar 31, 2022 | 18 | 6 | 50.00% |
| Dec 31, 2021 | 17 | 9 | 112.50% |
| Sep 30, 2021 | 15 | 7 | 87.50% |
| Jun 30, 2021 | 13 | - | - |
| Mar 31, 2021 | 12 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Ultragenyx Pharmaceutical | 1,371 |
| Beam Therapeutics | 522 |
| Arcutis Biotherapeutics | 354 |
| Alumis | 224 |
| Structure Therapeutics | 220 |
| Celldex Therapeutics | 198 |
| Disc Medicine | 154 |
| IDEAYA Biosciences | 145 |
VERA News
- 5 days ago - Vera Therapeutics price target lowered to $91 from $95 at Evercore ISI - TheFly
- 12 days ago - Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 13 days ago - Vera Therapeutics reports Q1 EPS ($1.69), consensus ($1.37) - TheFly
- 13 days ago - Vera Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 13 days ago - Vera Therapeutics Earnings release: Q1 2026 - Filings
- 13 days ago - Vera Therapeutics Quarterly report: Q1 2026 - Filings
- 16 days ago - Vera Therapeutics to Participate in the Bank of America Securities 2026 Health Care Conference - GlobeNewsWire
- 5 weeks ago - Vera Therapeutics Proxy statement: Proxy filing - Filings